Promoting effect of 12-O-tetradecanoylphorbol-13-acetate on the in vitro malignant transformation of fetal rat brain cells exposed in utero to ethylnitrosourea.
In order to investigate the possibility that the theory of two-stage carcinogenesis can be applied to neurogenic carcinogenesis, we analyzed the promoting effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on the in vitro malignant transformation of fetal rat brain cells exposed in utero to ethylnitrosourea (ENU). Rat brain cells were transferred to a cultured system at 72 h after a single pulse of ENU (50 mg/kg body weight) to pregnant SD-JCL rats on the 18th day of gestation. The positive findings of glial fibrillary acidic protein and S-100 protein in primary cultured cells by the analysis of immunohistochemistry revealed the neuroglial origin of transformed cells. These cells were divided into 12 groups and were treated twice per week with or without TPA at concentrations from 0.1 to 50.0 ng/ml. From the results of cellular morphology, Concanavalin A agglutinability, colony forming capacity in semisolid soft agar, and tumorigenicity in vivo, malignant transformation of fetal rat brain cells appeared earlier in the ENU group treated with TPA than in the untreated ENU group. On the basis of these observations, it is suggested that TPA might be effective as a tumor promoter on ENU-induced neurogenic carcinogenesis.
D000818:Animals; D001932:Brain Neoplasms / Q000139:chemically induced* / Q000473:pathology; D002449:Cell Aggregation; D002455:Cell Division; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D002478:Cells, Cultured; D003043:Cocarcinogenesis; D003208:Concanavalin A; D005038:Ethylnitrosourea / Q000494:pharmacology*; D005260:Female; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D008431:Maternal-Fetal Exchange; D009368:Neoplasm Transplantation; D014411:Neoplastic Stem Cells / Q000473:pathology; D010704:Phorbols / Q000494:pharmacology*; D011247:Pregnancy; D051381:Rats; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D005904:Glial Fibrillary Acidic Protein; D010704:Phorbols; D003208:Concanavalin A; D013755:Tetradecanoylphorbol Acetate; D005038:Ethylnitrosourea